GlassScriptPhysician profile
David Sosa
NPI 1760801799
$11,264.13
in general payments reported to CMS, 2019-2025
18 companies · $4,090 in 2025
The $4,090 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.21 · 2022: $520 · 2023: $2,397 · 2024: $4,170 · 2025: $4,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,717 · Travel and Lodging: $4,806 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,716.62 |
| Travel and Lodging | $4,806.11 |
| Education | $134.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,330.27 | 2023-2025 | Watchman Access System, Versacross Access Solution, Watchman Flx |
| Edwards Lifesciences Corporation | $2,246.67 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Philips North America LLC | $1,468.40 | 2024-2025 | Intracardiac Undivided, (Bs3) Intracardiac Und, (Bq9) Coronary Ivus |
| Abiomed | $925.14 | 2022-2025 | Impella |
| Abbott Laboratories | $591.68 | 2021-2025 | Cardiomems, Perclose Prostyle, Optis |
| Medtronic, INC. | $513.00 | 2021-2024 | Symplicity G3, Corevalve Evolut R, Selectsecure |
| Shockwave Medical, INC | $336.07 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $219.05 | 2023-2025 | Kengreal, Cleviprex |
| Cvrx, INC. | $172.09 | 2023 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $121.19 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $111.14 | 2022 | |
| W. L. Gore & Associates, INC. | $50.00 | 2024 | Gore-Tex Vascular Graft |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Biosense Webster, INC. | $43.83 | 2025 | Carto 3 |
| Terumo Medical Corporation | $30.33 | 2024 | Optitorque, Glidewire |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Pfizer INC. | $18.76 | 2024 | |
| Teleflex LLC | $14.89 | 2025 | Guideliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.